Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 3.905
-0.115 (-2.86%)
Aug 21, 2026, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 2.65 billion as of August 21, 2026. Its market cap has decreased by -38.81% in one year.
Market Cap
2.65B
Enterprise Value
2.07B
Revenue
652.54M
Ranking
n/a
PE Ratio
39.53
Stock Price
3.91
ChartMarket Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 2.65B, a decrease of -78.28%. That is a compound annual growth rate of -23.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.65B | 3.03% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viva Biotech Holdings | 3.28B |
| BioDlink International Company | 3.11B |
| Jiangsu Recbio Technology | 3.08B |
| HJ Science | 2.85B |
| Clover Biopharmaceuticals | 2.85B |
| Laekna | 2.73B |
| TYK Medicines | 2.68B |
| Shandong Boan Biotechnology | 2.68B |